Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 10
159
Views
0
CrossRef citations to date
0
Altmetric
Short communications

The estimation of permitted daily exposure (PDE) values for Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms, balsamum (balsam of Peru) for regulatory toxicology purposes: application of various toxicological strategies

ORCID Icon
Pages 1698-1701 | Received 05 May 2022, Accepted 10 Jul 2022, Published online: 29 Jul 2022

References

  • Aiello E. 2017. The safety assessment of herbals with a new and ethical approach. PhD course in “Pharmaceutical Science”, XXX cycle; [accessed 2022 Apr 25] http://www.fedoa.unina.it/12161/1/aiello_eugenio_30.pdf.
  • Aiello E, Russo R, Cristiano C, Calignano A. 2018. The safety assessment of herbals with a new and ethical approach. Nat Prod Res. 32(15):1838–1848.
  • Collier WA, Nitta Y. 1930. Über die Wirkung ätherischer Öle auf verschiedene Bakterienarten. Zeitschr. F. Hygiene. 111(3):301–312.
  • EMA/HMPC/712648/2014, Committee on Herbal Medicinal Products (HMPC), Assessment report on Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms, balsamum, 31 May 2016; [accessed 2022 Apr 25] https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-myroxylon-balsamum-l-harms-var-pereirae-royle-harms-balsamum_en.pdf.
  • Faria EC, Bercu JP, Dolan DG, Morinello EJ, Pecquet AM, Seaman C, Sehner C, Weideman PA. 2016. Using default methodologies to derive an acceptable daily exposure (ADE). Regul Toxicol Pharmacol. 79:S28–S38.
  • de Groot AC. 2019. Myroxylon pereirae resin (balsam of Peru) – A critical review of the literature and assessment of the significance of positive patch test reactions and the usefulness of restrictive diets. Contact Dermat. 80(6):335–353.
  • Hausen BM, Simatupang T, Bruhn G, Evers P, Koenig WA. 1995. Identification of new allergenic constituents and proof of evidence for coniferyl benzoate in Balsam of Peru. Am J Contact Dermat. 6(4):199–208.
  • Hayes EP, Jolly RA, Faria EC, Barle EL, Bercu JP, Molnar LR, Naumann BD, Olson MJ, Pecquet AM, Sandhu R, et al. 2016. A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing – Operational considerations. Regul Toxicol Pharm. 79:S39–S47.
  • Mammerler V. 2007. Contribution to the analysis and quality control of Peru Balsam [PhD thesis]. Vienna, Austria: University of Vienna; [accessed 2022 Apr 25] http://othes.univie.ac.at/4056/1/2009-03-23_0201578.pdf.
  • Riesmeier M, Mattonai M, Wong SS, Veall M-A, Betts J, Johnston M, Ribechini E, Devièse T. 2021. Molecular profiling of Peru Balsam reveals active ingredients responsible for its pharmaceutical properties. Nat Prod Res. 35(23):5311–5316.
  • Seo SM, Park HM, Park IK. 2012. Larvicidal activity of ajowan (Trachyspermum ammi) and Peru balsam (Myroxylon pereira) oils and blends of their constituents against mosquito, Aedes aegypti, acute toxicity on water flea, Daphnia magna, and aqueous residue. J Agric Food Chem. 60(23):5909–5914.
  • Tisserand R, Young R. 2013. Essential oil safety: a guide for health care professionals. Elsevier Health Sciences.
  • Veien NK, Hattel T, Justesen O, Norholm N. 1985. Oral challenge with balsam of Peru. Contact Dermatitis. 12(2):104–107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.